TOP GUIDELINES OF PF-05221304

[86] described that RG7834, a novel oral HBV gene expression inhibitor, could reduce the levels of viral proteins and decrease viremia. RG7834 is a little-molecule compound belonging into the dihydroquinolizinones chemical class just like RNAi but by another mechanism.Unlock Improved functions & substantial drug insights, together with in-depth int